<DOC>
	<DOC>NCT02057887</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of multiple ascending doses of HM10660A in subjects with chronic hepatitis C(HCV).</brief_summary>
	<brief_title>Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)</brief_title>
	<detailed_description>- To evaluate the repeat-dose pharmacokinetics (PK) of HM10660A when given by weekly, biweekly, and monthly subcutaneous (SC) injection. - To evaluate the repeat-dose pharmacodynamics (PD) of HM10660A when given by weekly, biweekly, and monthly SC injection. - To explore the antiviral activity of HM10660A at Week 4, Week 12, and Week 24.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Male or female, aged 18 to 65 years old, inclusive Willing and able to provide written informed consent. Previously untreated HCV infection with HCV RNA &gt; 75,000 IU/mL at screening. HCV genotype 1a or 1b. Body mass index (BMI) between 18 and 38 kg/m2. Willing and able to comply with the protocol and available to complete the study schedule of assessments. Pregnant women or women who may wish to become pregnant during the course of the study. Males and females of reproductive potential who are unwilling to use 2 forms of effective birth control throughout the duration of study treatment and for at least 6 months after the last dose of RBV. One method should include a condom with spermicide for males. Males must agree to refrain from sperm donation for at least 6 months after the last dose of RBV. Evidence of infection or coinfection with a nongenotype 1 HCV strain. Coinfection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV). Lactating females</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>